These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29567507)

  • 1. Acceptability of latent tuberculosis testing of migrants in a college environment in England.
    Walker CL; Duffield K; Kaur H; Dedicoat M; Gajraj R
    Public Health; 2018 May; 158():55-60. PubMed ID: 29567507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Usdin M; Dedicoat M; Gajraj R; Harrison P; Kaur H; Duffield K; Walker CL; Akram Y; Aiyedun V; Mohamed H; Zenner D
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):175-180. PubMed ID: 28234081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants.
    Hall J; Kabir TM; Shih P; Degeling C
    Aust N Z J Public Health; 2020 Oct; 44(5):353-359. PubMed ID: 32776658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area.
    Loutet MG; Burman M; Jayasekera N; Trathen D; Dart S; Kunst H; Zenner D
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.
    Berrocal-Almanza LC; Botticello J; Piotrowski H; Karnani N; Kon OM; Lalvani A; Zenner D
    Int J Tuberc Lung Dis; 2019 May; 23(5):563-570. PubMed ID: 31097064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris R; Lalor MK; Muzyamba MC; Were J; O'Connell AM; Mirza A; Kon OM; Lalvani A; Zenner D
    Lancet Infect Dis; 2019 Nov; 19(11):1191-1201. PubMed ID: 31471131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
    Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol.
    Rahman A; Thangaratinam S; Copas A; Zenner D; White PJ; Griffiths C; Abubakar I; McCourt C; Kunst H
    BMJ Open; 2022 Apr; 12(4):e058734. PubMed ID: 35379641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.
    Burman M; Copas A; Zenner D; Hickson V; Gosce L; Trathen D; Ashcroft R; Martineau AR; Abubakar I; Griffiths C; Kunst H
    BMC Public Health; 2019 Nov; 19(1):1598. PubMed ID: 31783742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
    Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
    BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.
    Zenner D; Loutet MG; Harris R; Wilson S; Ormerod LP
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-Specific Association Between Perceived Stigma Toward Tuberculosis and Acceptance of Preventive Treatment Among College Students With Latent Tuberculosis Infection: Cross-Sectional Analysis.
    Yuan Y; Jin J; Bi X; Geng H; Li S; Zhou C
    JMIR Public Health Surveill; 2023 Jun; 9():e43972. PubMed ID: 37314847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis, focussed tools and the right schools: estimated impact and cost of a targeted student screening programme for tuberculosis infection.
    Sawka A; Geake J; Stapledon R; Barry S
    Intern Med J; 2023 Jun; 53(6):978-984. PubMed ID: 35289041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
    Dara M; Solovic I; Sotgiu G; D'Ambrosio L; Centis R; Tran R; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Bothamley G; Schaberg T; Abubakar I; Teixeira V; Ward B; Gratziou C; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):808-17. PubMed ID: 27492827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.